Free Trial

Trading of Vigil Neuroscience was halted at 04:25 PM EST due to "News pending".

Vigil Neuroscience (VIGL) Short Interest Ratio & Short Volume

Vigil Neuroscience logo
$2.31 -0.17 (-6.85%)
Closing price 04:00 PM Eastern
Extended Trading
$2.32 +0.01 (+0.43%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vigil Neuroscience Short Interest Data

Vigil Neuroscience (VIGL) has a short interest of 360,700 shares, representing 1.59% of the float (the number of shares available for trading by the public). This marks a -14.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 478,058 shares to cover all short positions.

Current Short Interest
360,700 shares
Previous Short Interest
422,300 shares
Change Vs. Previous Month
-14.59%
Dollar Volume Sold Short
$757,470.00
Short Interest Ratio
1.7 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
46,672,000 shares
Float Size
22,620,000 shares
Short Percent of Float
1.59%
Today's Trading Volume
46,984 shares
Average Trading Volume
478,058 shares
Today's Volume Vs. Average
10%
Short Selling Vigil Neuroscience?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Vigil Neuroscience and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VIGL Short Interest Over Time

VIGL Days to Cover Over Time

VIGL Percentage of Float Shorted Over Time

Vigil Neuroscience Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2025360,700 shares $757,470.00 -14.6%1.6%1.7 $2.10
4/15/2025422,300 shares $654,565.00 -0.3%1.9%0.4 $1.55
3/31/2025423,500 shares $753,830.00 +1.0%1.9%0.4 $1.78
3/15/2025419,400 shares $847,188.00 -25.6%1.9%0.4 $2.02
2/28/2025564,000 shares $1.36 million -44.7%2.9%0.5 $2.42
2/15/20251,020,000 shares $2.82 million -43.7%5.2%1 $2.76
1/31/20251,810,000 shares $4.31 million +145.8%9.4%1.8 $2.38
1/15/2025736,500 shares $1.41 million +5.7%3.8%0.8 $1.92
12/31/2024696,900 shares $1.18 million +2.3%3.6%3.2 $1.70
12/15/2024681,400 shares $1.36 million -18.4%3.5%3.6 $1.99
11/30/2024835,500 shares $2.06 million +13.4%4.5%5.8 $2.47
11/15/2024736,700 shares $2.35 million +51.3%3.9%6.6 $3.19
10/31/2024487,000 shares $1.84 million -5.1%2.4%4.9 $3.78
10/15/2024513,300 shares $1.84 million -2.5%2.6%3.8 $3.58
9/30/2024526,600 shares $1.79 million -3.7%2.6%3.3 $3.40
9/15/2024546,600 shares $2.01 million -20.3%2.7%1.1 $3.67
8/31/2024685,800 shares $2.39 million -23.7%3.6%1.4 $3.48
8/15/2024899,200 shares $3.11 million +1.7%4.7%1.6 $3.46
7/31/2024884,100 shares $3.69 million -20.4%5.2%1.6 $4.17
7/15/20241,110,000 shares $4.66 million -48.4%7.1%2.1 $4.20
6/30/20242,150,000 shares $8.60 million +125.8%13.8%4.4 $4.00
6/15/2024952,100 shares $4.12 million +8.2%6.1%5.5 $4.33
5/31/2024880,200 shares $2.80 million -4.5%5.7%5.6 $3.18
5/15/2024922,000 shares $3.21 million -20.5%5.9%9.6 $3.48
4/30/20241,160,000 shares $3.03 million +26.0%4.6%12.3 $2.61
4/15/2024921,000 shares $2.91 million -6.8%6.2%10.5 $3.16
3/31/2024987,900 shares $3.37 million -5.0%7.1%10.9 $3.41
3/15/20241,040,000 shares $3.48 million +16.7%7.6%8.9 $3.35
2/29/2024891,100 shares $3.10 million +10.3%6.5%8.3 $3.48
2/15/2024807,800 shares $2.63 million +8.9%5.9%6.9 $3.25
1/31/2024742,000 shares $2.02 million +9.3%5.7%5.5 $2.72
1/15/2024678,600 shares $2.23 million -9.2%5.2%5.2 $3.28
12/31/2023747,400 shares $2.53 million +19.0%5.8%5.9 $3.38
12/15/2023628,100 shares $2.26 million -8.9%4.8%6 $3.60
11/30/2023689,700 shares $2.19 million -14.9%5.3%7.4 $3.18
11/15/2023810,600 shares $5.40 million +5.1%6.3%10.2 $6.66
10/31/2023771,100 shares $5.40 million -8.0%6.1%17.4 $7.00
10/15/2023838,200 shares $4.90 million -3.5%6.6%19.3 $5.84
9/30/2023868,300 shares $4.68 million +7.3%6.8%17.6 $5.39
9/15/2023809,500 shares $5.50 million +3.0%6.4%16.3 $6.79
Washington Is Broke—and Eyeing Your Savings Next (Ad)

Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.

Get your free guide now by clicking here >>
8/31/2023785,700 shares $4.74 million +8.8%5.4%9.7 $6.03
8/15/2023722,300 shares $4.22 million +31.7%4.9%8.8 $5.84
7/31/2023548,500 shares $4.46 million -24.0%3.8%6.9 $8.14
7/15/2023721,200 shares $6.74 million +4.5%5.0%9.5 $9.35
6/30/2023690,500 shares $6.49 million +45.2%4.8%9.9 $9.40
6/15/2023475,600 shares $4.76 million +0.1%3.3%7.1 $10.00
5/31/2023475,000 shares $4.75 million -14.6%3.3%16.4 $10.00
5/15/2023556,400 shares $4.80 million +4.4%3.9%22.8 $8.63
4/30/2023533,100 shares $4.64 million +5.7%3.7%23.9 $8.70
4/15/2023504,300 shares $4.80 million +9.5%3.5%25.1 $9.52
3/31/2023460,500 shares $4.51 million +2.8%3.2%22.8 $9.79
3/15/2023448,000 shares $3.98 million +4.8%3.9%20.3 $8.88
2/28/2023427,300 shares $5.13 million +0.5%3.7%14 $12.00
2/15/2023425,100 shares $4.89 million -1.1%3.0%13.1 $11.50
1/31/2023429,600 shares $4.66 million +7.0%3.3%12.2 $10.84
1/15/2023401,400 shares $4.80 million +1.6%3.1%10.9 $11.95
12/30/2022395,000 shares $4.94 million +29.5%3.0%10.4 $12.50
12/15/2022305,100 shares $3.82 million -0.2%2.3%8.7 $12.53
11/30/2022305,700 shares $3.82 million +8.2%2.3%12.5 $12.50
11/15/2022282,500 shares $3.11 million +1.2%2.2%13.3 $11.00
10/31/2022279,200 shares $4.38 million -4.7%2.7%16.8 $15.68
10/15/2022293,000 shares $4.68 million -1.7%2.8%17.3 $15.97
9/30/2022298,100 shares $2.71 million +0.2%N/A15.9 $9.10
9/15/2022297,600 shares $2.45 million -6.0%N/A7.1 $8.24
8/31/2022316,500 shares $2.72 million -2.8%N/A6.5 $8.60
8/15/2022325,600 shares $2.53 million -9.5%N/A6.1 $7.76
7/31/2022359,600 shares $2.39 million -9.1%N/A5.9 $6.65
7/15/2022395,600 shares $2.34 million No ChangeN/A6.3 $5.92

VIGL Short Interest - Frequently Asked Questions

What is Vigil Neuroscience's current short interest?

Short interest is the volume of Vigil Neuroscience shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 360,700 shares of VIGL short. 1.59% of Vigil Neuroscience's shares are currently sold short. Learn More on Vigil Neuroscience's current short interest.

What is a good short interest ratio for Vigil Neuroscience?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIGL shares currently have a short interest ratio of 2.0. Learn More on Vigil Neuroscience's short interest ratio.

What is a good short interest percentage for Vigil Neuroscience?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.59% of Vigil Neuroscience's floating shares are currently sold short.

Is Vigil Neuroscience's short interest increasing or decreasing?

Vigil Neuroscience saw a decrease in short interest in April. As of April 30th, there was short interest totaling 360,700 shares, a decrease of 14.6% from the previous total of 422,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Vigil Neuroscience's float size?

Vigil Neuroscience currently has issued a total of 46,672,000 shares. Some of Vigil Neuroscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vigil Neuroscience currently has a public float of 22,620,000 shares.

How does Vigil Neuroscience's short interest compare to its competitors?

1.59% of Vigil Neuroscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vigil Neuroscience: Cullinan Therapeutics, Inc. (20.91%), Altimmune, Inc. (27.84%), Sage Therapeutics, Inc. (8.48%), Tectonic Therapeutic (11.36%), SIGA Technologies, Inc. (10.24%), Tourmaline Bio, Inc. (19.89%), MeiraGTx Holdings plc (3.01%), Organogenesis Holdings Inc. (18.28%), PureTech Health plc (0.04%), COMPASS Pathways plc (5.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Vigil Neuroscience stock?

Short selling VIGL is an investing strategy that aims to generate trading profit from Vigil Neuroscience as its price is falling. VIGL shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Vigil Neuroscience?

A short squeeze for Vigil Neuroscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIGL, which in turn drives the price of the stock up even further.

How often is Vigil Neuroscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIGL, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:VIGL) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners